Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€37.48

€37.48

-0.120%
-0.045
-0.120%
€37.00

€37.00

 
17:47 / Tradegate WKN: 852009 / Symbol: PFE / Name: Pfizer / Stock / Pharmaceuticals / Large Cap /
Latest predictions
23.09.21
-0.54%
buy
€55.00
08.07.21
14.21%
buy
€37.00
17.05.21
15.50%
buy
13.05.21
15.71%
buy
€35.00
09.05.21
15.97%
buy
07.05.21
16.33%
Best running prediction
€35.09
07.04.16
58.05%
buy
Your prediction

Pfizer Inc. Stock

The price for the Pfizer Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.045 (-0.120%).
With 22 Buy predictions and 3 Sell predictions Pfizer Inc. is one of the favorites of our community.
On the other hand, the target price of €37.00 is below the current price of €37.48 for Pfizer Inc., so the potential is actually -1.281%.
Our community identified positive and negative aspects for Pfizer Inc. stock for the coming years. 9 users see the criterium "Worthwhile Investment for the next years" as a plus for the Pfizer Inc. stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.

Pros and Cons of Pfizer Inc. in the next few years

Pros
10
Could be worthwhile Investment >10% per year
7
Market Leader or Top 3
7
Known brand
Cons
3
Sustainability is little important

Performance of Pfizer Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Pfizer Inc. -0.120% 0.307% -6.874% 27.175% 24.050% 6.407% 32.230%
Merck & Co. Inc. 0.220% 2.865% -3.531% -12.003% -5.377% 4.717% 14.340%
Eli Lilly Corp. -2.000% 0.816% -11.044% 53.010% 45.426% 118.798% 178.364%
AbbVie Inc. 1.480% -0.512% -10.779% 23.220% 6.790% 13.094% 57.797%

Comments

Buy Pfizer Inc.
Show more

Sell Pfizer Inc.
Show more

Prediction Sell
Perf. (%) 23.59%
Target price 30.000
Change
Ends at 30.03.22

Sell with target price 30.0
Show more

Other discussions about Pfizer Inc. Stock

Trading Pfizer Inc.

Trading Pfizer Inc.

New thread Forum

News

Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults


Pfizer Inc. (NYSE: PFE) today announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for COVID-19 in Post-Exposure Prophylaxis) study to evaluate the investigational novel

Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analystshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analysts


Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 2, 2021. The

Pfizer Declares Fourth-Quarter 2021 Dividendhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Declares Fourth-Quarter 2021 Dividend


Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a 39-cent fourth-quarter 2021 dividend on the company’s common stock, payable December 6, 2021, to holders of the Common